Technical Analysis for SLRX - Salarius Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.40 | -0.71% | -0.01 |
SLRX closed down 0.71 percent on Wednesday, November 20, 2024, on 11 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | -0.71% | |
| Spinning Top | Other | -0.71% | |
| Narrow Range Bar | Range Contraction | -0.71% | |
| Inside Day | Range Contraction | -0.71% | |
| Wide Bands | Range Expansion | -0.71% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 17 hours ago |
| Rose Above 10 DMA | about 17 hours ago |
| Outside Day | about 17 hours ago |
| Up 3% | about 17 hours ago |
| Fell Below Previous Day's Low | about 17 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Salarius Pharmaceuticals, Inc. a clinical-stage oncology company, develops therapies for the treatment of patients with various cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Solid Tumors Clinical Development Oncology Breast Cancer Prostate Cancer Ovarian Cancer Treatment Of Breast Cancer Sarcoma Advanced Solid Tumors
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Solid Tumors Clinical Development Oncology Breast Cancer Prostate Cancer Ovarian Cancer Treatment Of Breast Cancer Sarcoma Advanced Solid Tumors
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.272 |
| 52 Week Low | 1.26 |
| Average Volume | 403,590 |
| 200-Day Moving Average | 2.96 |
| 50-Day Moving Average | 1.56 |
| 20-Day Moving Average | 1.51 |
| 10-Day Moving Average | 1.42 |
| Average True Range | 0.13 |
| RSI (14) | 42.20 |
| ADX | 9.92 |
| +DI | 23.11 |
| -DI | 21.18 |
| Chandelier Exit (Long, 3 ATRs) | 1.64 |
| Chandelier Exit (Short, 3 ATRs) | 1.73 |
| Upper Bollinger Bands | 1.75 |
| Lower Bollinger Band | 1.28 |
| Percent B (%b) | 0.26 |
| BandWidth | 30.88 |
| MACD Line | -0.07 |
| MACD Signal Line | -0.05 |
| MACD Histogram | -0.0129 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.56 | ||||
| Resistance 3 (R3) | 1.57 | 1.53 | 1.54 | ||
| Resistance 2 (R2) | 1.53 | 1.48 | 1.52 | 1.53 | |
| Resistance 1 (R1) | 1.46 | 1.46 | 1.45 | 1.45 | 1.52 |
| Pivot Point | 1.42 | 1.42 | 1.41 | 1.41 | 1.42 |
| Support 1 (S1) | 1.35 | 1.38 | 1.35 | 1.35 | 1.28 |
| Support 2 (S2) | 1.31 | 1.35 | 1.30 | 1.27 | |
| Support 3 (S3) | 1.24 | 1.31 | 1.26 | ||
| Support 4 (S4) | 1.24 |
